Alkylating agents are primarily used in the treatment of various cancers, including lymphomas, leukemias, and solid tumors. Their ability to induce DNA damage and cell death makes them valuable in chemotherapy regimens. However, their use must be carefully managed to balance therapeutic efficacy with potential toxicities.